A nuclear pore sub-complex restricts the propagation of Ty retrotransposons by limiting their transcription

PLoS Genet. 2021 Nov 1;17(11):e1009889. doi: 10.1371/journal.pgen.1009889. eCollection 2021 Nov.

Abstract

Beyond their canonical function in nucleocytoplasmic exchanges, nuclear pore complexes (NPCs) regulate the expression of protein-coding genes. Here, we have implemented transcriptomic and molecular methods to specifically address the impact of the NPC on retroelements, which are present in multiple copies in genomes. We report a novel function for the Nup84 complex, a core NPC building block, in specifically restricting the transcription of LTR-retrotransposons in yeast. Nup84 complex-dependent repression impacts both Copia and Gypsy Ty LTR-retrotransposons, all over the S. cerevisiae genome. Mechanistically, the Nup84 complex restricts the transcription of Ty1, the most active yeast retrotransposon, through the tethering of the SUMO-deconjugating enzyme Ulp1 to NPCs. Strikingly, the modest accumulation of Ty1 RNAs caused by Nup84 complex loss-of-function is sufficient to trigger an important increase of Ty1 cDNA levels, resulting in massive Ty1 retrotransposition. Altogether, our study expands our understanding of the complex interactions between retrotransposons and the NPC, and highlights the importance for the cells to keep retrotransposons under tight transcriptional control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genes, Fungal
  • Nuclear Pore / metabolism*
  • Nuclear Pore Complex Proteins / metabolism
  • RNA, Fungal / metabolism
  • Retroelements*
  • Saccharomyces cerevisiae / genetics
  • Saccharomyces cerevisiae Proteins / metabolism
  • Transcription, Genetic*

Substances

  • NUP84 protein, S cerevisiae
  • Nuclear Pore Complex Proteins
  • RNA, Fungal
  • Retroelements
  • Saccharomyces cerevisiae Proteins

Grants and funding

This study has been funded by: the Agence Nationale pour la Recherche, https://anr.fr/ (ANR-18-CE12-0003, to B.P., ANR-17-CE11-0025 to P.L), the initiatives d’excellence (Idex ANR-11-IDEX-0005-02 and the Labex “Who am I?”, http://www.labex-whoami.fr/fr/ ANR11-LABX-0071, to P.L., A.B. and B.P.), Fondation ARC pour la recherche sur le Cancer, https://www.fondation-arc.org/recherche-cancer (PJA 20181208112 to B.P., and PJA 20191209703 to P.L.), Ligue Nationale contre le Cancer, https://www.ligue-cancer.net/ (comité de Paris, to B.P.), Centre National de la Recherche Scientifique (CNRS), the Université de Paris and the Institut National de la Santé et de la Recherche Médicale (INSERM) (Apprenticeship contract to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.